In addition, novel CAR T-cell strategies such as armored CAR T-cells targeting vascular endothelial protein, CD248, can significantly inhibit tumor growth and metastasis by specifically attacking tumor-associated pericytes. The gene discussed is CD248; the disease is neoplasm.